Insider Buying: GE HealthCare Technologies (NASDAQ:GEHC) Director Purchases 1,618 Shares of Stock

GE HealthCare Technologies Inc. (NASDAQ:GEHC) Director Rodney Hochman purchased 1,618 shares of GE HealthCare Technologies stock in a transaction that occurred on Tuesday, May 12th. The shares were bought at an average cost of $62.03 per share, for a total transaction of $100,364.54. Following the transaction, the director directly owned 1,618 shares of the company’s stock, valued at $100,364.54. This represents a ? increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

GE HealthCare Technologies Price Performance

NASDAQ:GEHC traded down $0.40 during trading hours on Wednesday, reaching $61.89. 4,168,247 shares of the company were exchanged, compared to its average volume of 4,156,959. The company has a market capitalization of $28.15 billion, a P/E ratio of 14.81, a P/E/G ratio of 1.39 and a beta of 0.74. GE HealthCare Technologies Inc. has a 1-year low of $58.75 and a 1-year high of $89.77. The company has a debt-to-equity ratio of 0.95, a current ratio of 1.22 and a quick ratio of 0.95. The business has a 50 day moving average of $70.62 and a 200 day moving average of $77.06.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.08). The company had revenue of $5.13 billion for the quarter, compared to analyst estimates of $5.04 billion. GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.The company’s quarterly revenue was up 7.4% compared to the same quarter last year. During the same period in the prior year, the company earned $1.01 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. Research analysts forecast that GE HealthCare Technologies Inc. will post 4.89 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Friday, April 3rd will be issued a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date of this dividend is Thursday, April 2nd. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 3.35%.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the company. Laurel Wealth Advisors LLC bought a new position in shares of GE HealthCare Technologies in the 4th quarter valued at $26,000. Optima Capital LLC bought a new position in shares of GE HealthCare Technologies in the 4th quarter valued at $27,000. Godfrey Financial Associates Inc. bought a new position in shares of GE HealthCare Technologies in the 4th quarter valued at $27,000. Montag A & Associates Inc. lifted its stake in shares of GE HealthCare Technologies by 105.4% in the 4th quarter. Montag A & Associates Inc. now owns 341 shares of the company’s stock valued at $28,000 after acquiring an additional 175 shares during the last quarter. Finally, Transamerica Financial Advisors LLC lifted its stake in shares of GE HealthCare Technologies by 331.6% in the 4th quarter. Transamerica Financial Advisors LLC now owns 341 shares of the company’s stock valued at $28,000 after acquiring an additional 262 shares during the last quarter. 82.06% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on the company. The Goldman Sachs Group downgraded GE HealthCare Technologies from a “buy” rating to a “neutral” rating and reduced their target price for the company from $81.00 to $65.00 in a report on Thursday, April 30th. Barclays reduced their target price on GE HealthCare Technologies from $87.00 to $78.00 and set an “equal weight” rating on the stock in a report on Thursday, April 30th. Piper Sandler reduced their target price on GE HealthCare Technologies from $88.00 to $74.00 in a report on Thursday, April 30th. Mizuho reduced their target price on GE HealthCare Technologies from $90.00 to $80.00 in a report on Thursday, April 30th. Finally, Oppenheimer reaffirmed an “outperform” rating and issued a $85.00 target price on shares of GE HealthCare Technologies in a report on Thursday, April 30th. Eight investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $80.67.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.